For 503B Outsourcing Facility Leaders
The 503B Regulatory Cliff Playbook
On June 29, 2026, the FDA closes the comment window on removing GLP-1s from the 503B Bulks List. Inspections will intensify. Your historical authorization decisions are about to get walked backward.
This playbook is the 90-day plan for surviving that reconstruction.
Sample page
Section 4.3 — EAC Authorization Decision Tree
One of 12 ready-to-use templates inside the playbook. Codifies the authorization standard an FDA investigator will apply when reconstructing a compounding decision under the "Essentially a Copy" provision of FDCA Section 503B. Embed it in your order intake by Day 50.
Three branches. Three outcomes. Every order exits with a reconstructable authorization record: branch taken, evidence reviewed, decision owner, timestamp.
From the playbook
Execution evidence survives audit.
Authorization evidence survives reconstruction.
Section 1.3 — Execution Evidence vs. Authorization Evidence
What's inside
The 90-day plan
- Week-by-week actions, named owners, deadlines
- Stop-loss authorization policy (template, ready Day 3)
- SKU authorization ledger framework
- Cleanroom defense playbook (ISO 5 reconstruction drill)
- Customer continuity brief (white-label-ready)
Reference tools (12 templates)
- EAC Authorization Decision Tree
- Significant Difference attestation
- 30-second reconstruction test
- Reinspection liability reserve model
- Executive briefing one-pager
- The Binder Test
Role scorecards
- COO — yield and uptime without compromise
- Head of Quality & Regulatory — reconstruction on demand
- CFO — cash protection and audit cost containment
- Each with KPI targets and Day-X deliverables
Choose your tier
Playbook
$497
The PDF and 12 templates.
- Instant PDF download
- 12 ready-to-use templates
- 90-day plan with named owners and deadlines
Most chosen
Playbook + Live Reconstruction
$997
See your actual authorization decisions reconstructed inside the IRR.
- Everything in the Playbook tier
- 45-minute live reconstruction session
- Bring a recent release, CFU continuation, or EAC determination
- Watch the authorization logic surface in real time
Playbook + 60-Day IRR Trial
$1,497
The full reconstruction toolkit, embedded for 60 days.
- Everything in the Reconstruction tier
- 60 days of full IRR Individual access ($1,998 value)
- Auto-continues at $999/mo after day 61 — cancel anytime
Three questions to test before you buy
Run these mentally. If you can answer all three in under a minute, you don't need the playbook.
- Pick one batch released in the last 90 days where an environmental excursion was overridden to continue. Can your team produce the authorization rationale — who, what evidence, why justified — in under a minute? Not the data. The reasoning.
- Pull a non-shortage compound shipped in the last 30 days. Can you surface the prescriber-documented significant difference, linked to that specific order, that authorized it?
- Name the last CFU investigation closed on your floor. Without opening the binder, can you reconstruct the disposition logic that closed it?
If any answer is "we'd have to go look," that's the reconstruction gap. The playbook closes it before June 29.
The Record Behind the Decision.